SUNNYVALE,Calif., –Cepheid (NASDAQ: CPHD) today announced the release of an updated Xpert BCR-ABL Monitor test, now incorporating lot-specific standardization using the WHO (World Health Organization) BCR-ABL standards. The test is being released as a European CE-IVD Mark product under the European Directive on In Vitro Diagnostic Medical Devices. The test, which runs on Cepheid’s GeneXpert […]
ROTKREUZ, Switzerland and PLEASANTON, Calif., — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it now offers an expanded portfolio of blood screening solutions with an integrated serology testing offering*. Roche is the global leader in the blood screening business based on its long-term success in nucleic acid testing (NAT). The addition of the […]
INDIANAPOLIS, — Roche Diabetes Care, makers of ACCU-CHEK® products and services, is pleased to announce the availability of the new, user-friendly ACCU-CHEK Nano SmartView System. The ACCU-CHEK Nano meter, part of the ACCU-CHEK Nano SmartView System, offers enhanced features including: ease-of-use, fast and accurate readings and small, portable size. Moreover, the meter offers patients the […]
CARLSBAD, Calif., — Life Technologies Corporation (NASDAQ: LIFE) today announced the acquisition of Pinpoint Genomics, Inc., and its early-stage non-small cell lung cancer test that can help doctors identify those early-stage patients at high risk for progression to late-stage disease. Lung cancer is currently the leading cause of cancer deaths worldwide, claiming close to 1.5 […]
Franklin Lakes, NJ – The Board of Directors of BD (Becton, Dickinson and Company) (NYSE:BDX) has declared a quarterly dividend of 45 cents per common share, payable on September 28, 2012 to holders of record on September 7, 2012. The indicated annual dividend rate is $1.80 per share. About BD BD is a leading global […]
CARLSBAD, Calif., — Life Technologies Corporation (NASDAQ: LIFE ) today announced a collaboration with the Southern African Treatment and Resistance Network (SATuRN — https://www.bioafrica.net/saturn) on sequencing-based diagnostics for HIV-infected individuals in Africa. Antiretroviral (ARV) drugs are becoming increasingly available in the developing world, due to facilitation by both governmental and non-governmental organizations, as well as […]
SAN DIEGO and CARLSBAD, Calif., — Gen-Probe Incorporated (NASDAQ: GPRO) and Life Technologies Corporation (NASDAQ: LIFE) today announced they have signed a distribution agreement for SeCore® HLA Sequence-Based Typing (SBT) kits for use with Life Technologies’ 3500 Dx Genetic Analyzer. Under the terms of the agreement, Gen-Probe’s LIFECODES unit will have co-exclusive rights to sell […]
OMAHA, Neb. (July 24, 2012) – Transgenomic, Inc. (OTC/BB: TBIO) today announced that National Government Services, the designated Medicare fiscal intermediary in Connecticut, has confirmed coverage for its proprietary Clopidogrel Genetic Absorption Activation Panel (C-GAAP, formerly PGxPREDICT®:Clopidogrel). As a result of this coverage, the 48 million Americans currently covered by Medicare will have access to […]
Wetzlar, Germany. Leica Microsystems announces the release of the SCN400 2.2 scanning platform. Batch processing in both brightfield and multi-channel fluorescence, coupled with user-friendly workflows, makes the SCN400 2.2 an all-round high performance solution for digital pathology scanning. With up to 5 fluorescence channels per slide, the SCN400 2.2 provides a truly flexible whole slide […]
WALTHAM, Mass. — PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, announced today that its DNA Sequencing Services Laboratory in Branford, Connecticut is now a Connecticut state licensed and CLIA registered clinical laboratory (CT license # CL0685). PerkinElmer’s DNA Sequencing Services Laboratory is designed to provide […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
